Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest osteopenia Stories

2013-12-19 16:27:58

NORTHBROOK, Ill., Dec. 19, 2013 /PRNewswire/ -- A research study published earlier this week in a supplement of Osteoporosis International, the official journal of the International Osteoporosis Foundation and National Osteoporosis Foundation, substantiates significant increases in bone mineral density (BMD) among seniors using a new exercise system designed for osteogenic loading. This marks the first time the use of any non-pharmaceutical protocol has been shown to increase bone...

2013-11-27 23:22:32

Reportbuyer.com just published a new market research report: Osteopenia Global Clinical Trials Review, H2, 2013. London (PRWEB) November 27, 2013 Osteopenia Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Osteopenia Global Clinical Trials Review, H2, 2013" provides data on the Osteopenia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Osteopenia. It includes an overview of the...

2013-09-19 12:28:09

TORONTO, Sept. 19, 2013 /CNW/ - All across Canada this week, Osteoporosis Canada is hosting community events to raise awareness among Canadians about the seriousness of a broken bone. Not all broken bones are what they seem; sometimes, there are underlying causes that could lead to more broken bones if the individual is not properly assessed and treated. "It is not normal when a broken bone is caused by something as simple as a slip or fall from standing height, or making a bed...

2013-09-17 23:30:16

Vitamin E tocotrienols may soon be sharing the platform with other bone health supplements, suggests a recent study using American River Nutrition’s DeltaGold® annatto tocotrienol supplement with or without statins in osteoporotic rats. Hadley, MA (PRWEB) September 17, 2013 Annatto tocotrienol – mainly composed of delta-tocotrienol – given with or without statins stimulated bone formation and cut back bone decay in a postmenopausal osteoporosis rat model, according to findings...

2013-04-04 08:29:41

Greater Reduction in the Risk of Vertebral Fracture is One of the Greatest Unmet Needs in Osteoporosis and Osteopenia, According to a New Report from Decision Resources BURLINGTON, Mass., April 4, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European primary care physicians (PCPs) agree that efficacy on hip fracture risk reduction is one of the attributes that...

2012-11-27 16:25:54

SACRAMENTO, Calif., Nov. 27, 2012 /PRNewswire/ -- Whether its sledding, skiing or perhaps preparing a holiday feast, consumers should take note that the chances of breaking a bone double during the winter months. Cold weather has been linked with broken bones and strains, stiff joints and heightened chances of slips and falls for those with arthritis and other bone and joint diseases.[1] (Logo: http://photos.prnewswire.com/prnh/20121127/SF19554LOGO) "Protecting bones and increasing bone...

2012-11-22 20:20:28

Provinical Governments List Aclasta on Public Drug Plans TORONTO, Nov. 22, 2012 /CNW/ - Osteoporosis Canada congratulates the Ontario government, the New Brunswick government, the Saskatchewan government and the British Columbia government for providing access to a new osteoporosis medication. Aclasta (zoledronic acid) is now available on public and private drug plans in Ontario, BC, SK, and NB meaning Canadians at high risk for fractures have access to increased treatment...

2012-10-16 07:28:04

BOONTON, N.J., Oct. 16, 2012 /PRNewswire/ -- Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today announced that its licensee, Tarsa Therapeutics, reported that a Phase 2 trial of its oral recombinant salmon calcitonin in the prevention of postmenopausal osteoporosis was successfully concluded and yielded statistically significant, clinically relevant improvements in bone mineral density (BMD) at the...

2012-10-16 07:26:37

MINNEAPOLIS and PHILADELPHIA, Oct. 16, 2012 /PRNewswire/ -- Tarsa Therapeutics, Inc. today announced that a Phase II trial of its oral recombinant salmon calcitonin in the prevention of postmenopausal osteoporosis was successfully concluded and yielded statistically significant, clinically relevant improvements in bone mineral density (BMD) at the lumbar spine. These data were presented at the American Society for Bone and Mineral Research (ASBMR) 2012 Annual Meeting by Phase II investigator...

2012-06-11 06:24:54

Northwestern Medicine expert offer tips for enhancing bone health in early adulthood to avoid osteoporosis in later years CHICAGO, June 11, 2012 /PRNewswire-USNewswire/ -- While women are disproportionately affected by osteoporosis, growing evidence suggests that all adults need to take proactive measures for prevention. Northwestern Medicine® experts say it's important for men to know their risk too and point to a significant amount of evidence that suggests actions to minimize...